Top Markets
Coin of the day
InnoPharmax Inc. InnoPharmax Inc.

InnoPharmax Inc.

4172
Clasificación en acciones #26286
InnoPharmax Inc., established in 1994 and headquartered in Taipei, Taiwan,... InnoPharmax Inc., established in 1994 and headquartered in Taipei, Taiwan, operates as a specialized pharmaceutical enterprise. The company's core activities revolve around the development and market introduction of therapeutic products, with a particular focus on oncology and various other specialized medical fields within the Taiwanese market. Their current commercial portfolio encompasses N11005, an oral insulin designed for administration with meals, alongside GemOral. They also provide an Imipenem and Cilastatin solution, utilized for treating a broad spectrum of bacterial infections affecting areas such as the lower respiratory tract, skin and soft tissue, internal abdominal organs, gynecological systems, and bone and joints. Furthermore, InnoPharmax offers contrast agents, specifically gadopentetate dimeglumine and gadodiamide; oncology medications like Innomustine and Immurin; and Inpheno tablets, which are indicated for rare diseases. The company also provides advanced technology platforms, including the MUCR system, OralPas, and OralPas Pro. Looking at its research and development pipeline, InnoPharmax has several promising candidates. D07001 is currently in Phase I clinical trials for tumor treatment. C08001 has progressed to Phase III, targeting hypertension, heart failure, and left ventricular dysfunction following a myocardial infarction. Additional compounds in pilot bioequivalence (BE) trials include D07002, a potential supplement for phenylketonuria; C07001 for the management of Parkinson's disease; and N11001, which is being investigated for urological applications. The company is also actively formulating new contrast agents, D0131502 and D0051301.
Precio por acción
$0.35614911
Capitalización bursátil
$41.95M
Cambio (1 día)
0.45%
Cambio (1 año)
-50.84%
País
TW
Comercio InnoPharmax Inc. (4172)

Categoría

Historial del precio de la acción de InnoPharmax Inc. (4172)
Precio más alto de cierre: $0.36 el 2026-08-01

Precio más bajo de cierre: $1.06 el 2012-09-01
Historial del precio de la acción de InnoPharmax Inc. desde 2012 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -12.39%
2025 7.46%
2024 -12.87%
2023 61.93%
2022 -33.63%
2021 -6.90%
2020 77.08%
2019 51.95%
2018 -61.37%
2017 -36.95%
2016 -31.63%
2015 -6.68%
2014 -10.05%
2013 25.88%
2012 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$163.75 25.86%
DE
$38.00 22.72%
JP
$220.05 32.92%
CH
$21.01 11.96%
IN